Hui Fang
Publications by Year
Research Areas
Diabetes Treatment and Management, Metabolism, Diabetes, and Cancer, Neurological Disease Mechanisms and Treatments, Colorectal Cancer Surgical Treatments, Nerve injury and regeneration
Most-Cited Works
- → Low BDNF is associated with cognitive deficits in patients with type 2 diabetes(2012)123 cited
- → Dorzagliatin monotherapy in Chinese patients with type 2 diabetes: a dose-ranging, randomised, double-blind, placebo-controlled, phase 2 study(2018)101 cited
- → Efficacy and Safety of Tangshen Formula on Patients with Type 2 Diabetic Kidney Disease: A Multicenter Double-Blinded Randomized Placebo-Controlled Trial(2015)87 cited
- → Prevalence and risk factors of diabetic peripheral neuropathy: A population‐based cross‐sectional study in China(2023)81 cited
- → Liraglutide improves cognitive impairment via the AMPK and PI3K/Akt signaling pathways in type 2 diabetic rats(2018)72 cited
- → Efficacy and safety of chiglitazar, a novel peroxisome proliferator-activated receptor pan-agonist, in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, phase 3 trial (CMAP)(2021)57 cited
- → Prevalence of painful diabetic peripheral neuropathy in type 2 diabetes mellitus and diabetic peripheral neuropathy: A nationwide cross-sectional study in mainland China(2023)56 cited
- → Sulforaphane Prevents Neuronal Apoptosis and Memory Impairment in Diabetic Rats(2016)54 cited
- → Vildagliptin, a DPP4 inhibitor, alleviates diabetes‑associated cognitive deficits by decreasing the levels of apoptosis‑related proteins in the rat hippocampus(2018)43 cited
- → Long noncoding RNA are aberrantly expressed in human papillary thyroid carcinoma(2016)41 cited